<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-pharmaceuticals-13-00096">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tseng</surname>
    <given-names>C.-T.</given-names>
   </name>
   <name>
    <surname>Sbrana</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Iwata-Yoshikawa</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Newman</surname>
    <given-names>P.C.</given-names>
   </name>
   <name>
    <surname>Garron</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Atmar</surname>
    <given-names>R.L.</given-names>
   </name>
   <name>
    <surname>Peters</surname>
    <given-names>C.J.</given-names>
   </name>
   <name>
    <surname>Couch</surname>
    <given-names>R.B.</given-names>
   </name>
  </person-group>
  <article-title>Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus</article-title>
  <source>PLoS ONE</source>
  <year>2012</year>
  <volume>7</volume>
  <elocation-id>e35421</elocation-id>
  <pub-id pub-id-type="doi">10.1371/annotation/2965cfae-b77d-4014-8b7b-236e01a35492</pub-id>
  <pub-id pub-id-type="pmid">22536382</pub-id>
 </element-citation>
</ref>
